Combination of intramuscular transplantation of autologous mononuclear bone marrow cells with sympathectomy (L2, 3) in patients with peripheral arterial disease(PAD).
In most patients with severe, chronic extremity ischemic diseases, intervention or surgical treatment is often not suitable. Combination of intramuscular transplantation of autologous monocular bone marrow cells (AMBMCs) and sympathectomy (L2, 3) has been proved therapeutically beneficial.We studied 170 patients (combined group 80, control group 90) with extremity ischemia (TAO, ASO FontaineⅡ,Ⅲ, Ⅳ) between January 2013 and September 2019.In contrast to pre-operation, the walking distance of patients increased significantly (from 61.34 ± 52.23 m to 156.0 ± 32.4 m, p
View the full article @ The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland
Authors: Il-Su Jo, Hyon-Jong Kim, Myong-Hwan Chae, Un-Chol Kwon, Gwang-Hak Ju, Un Song, Chol-Ho Hyon, Il-Su Kim